Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families

[1]  M. Lebwohl,et al.  Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. , 2016, Journal of the American Academy of Dermatology.

[2]  K. Jarnagin,et al.  Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies. , 2016, Immunotherapy.

[3]  T. Han,et al.  Correlation between Severity of Atopic Dermatitis and Sleep Quality in Children and Adults , 2016, Annals of dermatology.

[4]  Z. Draelos,et al.  Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open‐Label, Maximal‐Use Systemic Exposure Study , 2016, Pediatric dermatology.

[5]  M. Suárez-Fariñas,et al.  Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizer. , 2016, The Journal of allergy and clinical immunology.

[6]  W. Tom,et al.  Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open‐Label Phase 2a Study , 2016, Pediatric dermatology.

[7]  M. Spellman,et al.  A Phase 2, Randomized, Controlled, Dose-Ranging Study Evaluating Crisaborole Topical Ointment, 0.5% and 2% in Adolescents With Mild to Moderate Atopic Dermatitis. , 2015, Journal of drugs in dermatology : JDD.

[8]  D. Murrell,et al.  Crisaborole Topical Ointment, 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept Study. , 2015, Journal of drugs in dermatology : JDD.

[9]  V. Lee,et al.  Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema , 2015, The Journal of dermatological treatment.

[10]  S. Nutten.  Atopic Dermatitis: Global Epidemiology and Risk Factors , 2015, Annals of Nutrition and Metabolism.

[11]  A. Finlay,et al.  Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data , 2015, Dermatology.

[12]  H. Williams,et al.  Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention , 2014, The Journal of allergy and clinical immunology.

[13]  Yao-Hsu Yang,et al.  Atopic Dermatitis, Melatonin, and Sleep Disturbance , 2014, Pediatrics.

[14]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. , 2014, Journal of the American Academy of Dermatology.

[15]  R. Stern,et al.  Suicidal ideation, mental health problems, and social function in adolescents with eczema: a population-based study. , 2014, The Journal of investigative dermatology.

[16]  J. Silverberg,et al.  Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[17]  A. Finlay,et al.  Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995–2012 , 2013, The British journal of dermatology.

[18]  A. Finlay,et al.  The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application , 2013, The British journal of dermatology.

[19]  S. Spector,et al.  Atopic dermatitis: a practice parameter update 2012. , 2013, The Journal of allergy and clinical immunology.

[20]  E. Simpson.  Comorbidity in Atopic Dermatitis , 2012, Current Dermatology Reports.

[21]  A. Armstrong,et al.  Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010 , 2011, PloS one.

[22]  P. Beattie,et al.  severity stratification of Children's Dermatology Life Quality Index (cdlqi) scores : pa-8 , 2010 .

[23]  T. Mücke,et al.  Expression of antimicrobial peptides in cutaneous infections after skin surgery , 2010, The British journal of dermatology.

[24]  S. Lewis-jones.  Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema , 2006, International journal of clinical practice.

[25]  A. Muraro,et al.  Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. , 2006, The Journal of allergy and clinical immunology.

[26]  P. Beattie,et al.  A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases , 2006, The British journal of dermatology.

[27]  A. Finlay,et al.  Translating the science of quality of life into practice: What do dermatology life quality index scores mean? , 2005, The Journal of investigative dermatology.

[28]  U. Wahn,et al.  Treatment of infants with atopic eczema with pimecrolimus cream 1% improves parents’ quality of life: A multicenter, randomized trial , 2005, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[29]  Rajesh Balkrishnan,et al.  The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society , 2005, Pediatric dermatology.

[30]  G. Jemec,et al.  Time Spent on Treatment of Atopic Dermatitis: A New Method of Measuring Pediatric Morbidity? , 2004, Pediatric dermatology.

[31]  D. Whalley,et al.  The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis. , 2002, Pediatrics.

[32]  A. Lucky,et al.  Use of an Emollient As a Steroid‐Sparing Agent in the Treatment of Mild to Moderate Atopic Dermatitis in Children , 1997, Pediatric dermatology.

[33]  G. Varigos,et al.  Atopic eczema: its impact on the family and financial cost , 1997, Archives of disease in childhood.

[34]  A Y Finlay,et al.  The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use , 1995, The British journal of dermatology.

[35]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[36]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[37]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.

[38]  D. Meads,et al.  Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? , 2012, The Journal of investigative dermatology.

[39]  T. Bieber.  Invited Review Article : Atopic Dermatitis , 2010 .

[40]  T. Bieber.  Atopic dermatitis. , 2010, Annals of dermatology.

[41]  Thomas Bieber,et al.  Atopic dermatitis. , 2008, The New England journal of medicine.

[42]  K. Beusterien,et al.  The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. , 2001, Journal of the American Academy of Dermatology.